ZELBORAF (Genentech, Inc.)
Welcome to the PulseAid listing for the ZELBORAF drug offered from Genentech, Inc.. This Kinase Inhibitor [EPC],Protein Kinase Inhibitors [MoA],Cytochrome P450 1A2 Inhibitors [MoA],P-Glycoprotein Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Genentech, Inc. |
NON-PROPRIETARY NAME: | Vemurafenib |
SUBSTANCE NAME: | VEMURAFENIB |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Kinase Inhibitor [EPC],Protein Kinase Inhibitors [MoA],Cytochrome P450 1A2 Inhibitors [MoA],P-Glycoprotein Inhibitors [MoA] |
ROUTE: | ORAL |
DOSAGE FORM: | TABLET, FILM COATED |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 2011-08-17 |
END MARKETING DATE: | 0000-00-00 |
ZELBORAF HUMAN PRESCRIPTION DRUG Details:
Item Description | ZELBORAF from Genentech, Inc. |
LABELER NAME: | Genentech, Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 240(mg/1) |
START MARKETING DATE: | 2011-08-17 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 50242-090_12027f5f-f87f-4551-9ca0-1978bfbd1494 |
PRODUCT NDC: | 50242-090 |
APPLICATION NUMBER: | NDA202429 |
Other VEMURAFENIB Pharmaceutical Manufacturers / Labelers: